Observational studyJournal of thrombosis and thrombolysis2025
Parameters of rotational thromboelastometry in patients with moderate and severe psoriasis: a pilot study.
Observational study in Journal of thrombosis and thrombolysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSeveral studies have repeatedly described an increased risk of thrombotic complications in patients with severe psoriasis. Rotational thromboelastometry (ROTEM) is a viscoelastic hemostatic test that allows sophisticated in-vivo evaluation of hemostasis in whole blood samples. This study aimed to assess hemostatic changes in psoriatic patients using ROTEM.
methodsThis pilot, observational, prospective study included 62 patients with moderate and severe psoriasis and a control group of 61 healthy blood donors. Blood samples were tested using the ROTEM Gamma analyser (Pentapharm GmbH, Munich, Germany) with INTEM, EXTEM, and FIBTEM reagents. We measured clotting time (CT), clot formation time (CFT), maximum clot firmness (MCF), amplitude at 10 and 20 min post-CT (A10, A20) and alpha angle.
resultsThe psoriatic patient group consisted of 31 men and 31 women, while the control group included 34 men and 27 women. Comparing patients with psoriasis and the control group, we identified statistically significant differences in the parameters: CT-EXTEM (74.8±1.4s vs. 69.7±1.4s; p < 0.05), MCF-EXTEM, A10-EXTEM, A20-EXTEM, CFT-INTEM, A10-INTEM, A20-INTEM, alfa-INTEM, CT-FIBTEM (67.3±1.2s vs. 62.8±1.2s; p < 0.05), CFT-FIBTEM and alfa-FIBTEM.
conclusionsIn this pilot study, compared to the controls, patients with moderate to severe psoriasis exhibited a shift in hemostasis towards a procoagulant state in ROTEM analysis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.